iiinova — where your digital self keeps evolving

Reposted by Dr Diana Schuhmacher

OzMRS @ozmrs.bsky.social · 15/09/2026

Save the date! Our first virtual seminar of our ECR Miniseries will occur on the 23rd of November, 2026. Are you a PhD student or ECR interested in sharing your research with the wider Australasian metastasis research field? Submit your abstract: tinyurl.com/2s3a5b2n

032

Reposted by Dr Diana Schuhmacher

OzMRS @ozmrs.bsky.social · 17/07/2026

In this month's research spotlight, read about @pajiclab.bsky.social postdoc and 2025 OzMRS ECR Symposium Best Poster award winner @drdianaschuhmacher.bsky.social, and her work uncovering mechanisms driving metastasis in pancreatic cancer at the @garvaninstitute.bsky.social. www.ozmrs.com/spotlight

ozmrs.com

Researcher Spotlight | OzMRS

022

Reposted by Dr Diana Schuhmacher

OzMRS @ozmrs.bsky.social · 29/10/2025

Day 2 Session 1 continued with presentations from A/Prof @samstehbens.bsky.social, Dr Gary Tincknell, @drdianaschuhmacher.bsky.social, and Ashna Kumar. #7thOzMRSScientificSymposium

052

Reposted by Dr Diana Schuhmacher

OzMRS @ozmrs.bsky.social · 16/09/2025

Would you like to get updates about Australasian metastasis research straight to your inbox every month? Register with OzMRS and you'll receive a newsletter once a month updating you on the latest and best of Australasian metastasis research. www.ozmrs.com

044

Reposted by Dr Diana Schuhmacher

Pancreatic Cancer Therapeutics Research Program @pajiclab.bsky.social · 08/07/2025

Our latest publication in @theaacr.bsky.social's Molecular Cancer Therapeutics is out! We've developed a new patient-derived model of a rare cancer, TFCP2-rearranged intraosseous rhabdomyosarcoma, and validated a promising preclinical treatment approach for this disease. doi.org/10.1158/1535...

doi.org

Integration of whole genome sequencing analysis with unique patient-derived models reveals clinically relevant drug targets in TFCP2 fusion-defined rhabdomyosarcoma

Abstract. Precision medicine is a likely future for all cancer treatment, but may have its greatest impact for less common, high-mortality and molecularly heterogeneous cancers. TFCP2-rearranged Rhabd...

041

Reposted by Dr Diana Schuhmacher

OzMRS @ozmrs.bsky.social · 21/05/2025

A big welcome to our three new OzMRS committee members @sharissa-latham.bsky.social, @vaibhavijoshi.bsky.social, and @drdianaschuhmacher.bsky.social, who are our new digital content co-managers. To read more about our new committee members, see the link below: www.ozmrs.com/committee

ozmrs.com

OzMRS Committee | OzMRS

052

Dr Diana Schuhmacher @drdianaschuhmacher.bsky.social · 23/03/2025

I really enjoyed this opportunity and the chance to connect with the wider community affected by pancreatic cancer.

051

Reposted by Dr Diana Schuhmacher

Pancreatic Cancer Therapeutics Research Program @pajiclab.bsky.social · 11/03/2025

We’re walking in PanKind Australian Research Foundation’s #PutYourFootDown in #Sydney on March 23rd and cannot wait! If you can, please consider supporting us! pankind.grassrootz.com/2025-pyfd-sy....

pankind.grassrootz.com

Team Pajic Lab in Put Your Foot Down 2025 Sydney

021

Reposted by Dr Diana Schuhmacher

Pancreatic Cancer Therapeutics Research Program @pajiclab.bsky.social · 14/02/2025

Yesterday at Lorne Cancer we were represented by our postdoc Diego presenting a flashtalk on use of itraconazole as a novel treatment for #PancreaticCancer, while PhD students Aji and Johana presented posters on T cell-cancer cell interactions and epigenetics. #LorneCancerConference

041

Reposted by Dr Diana Schuhmacher

Pancreatic Cancer Therapeutics Research Program @pajiclab.bsky.social · 14/02/2025

Today our postdocs @drdianaschuhmacher.bsky.social and @drdeannamiller.bsky.social presented posters on their research into use of small molecule inhibitors and clonal evolution of metastases in #PancreaticCancer #LorneCancerConference

021

Reposted by Dr Diana Schuhmacher

Pancreatic Cancer Therapeutics Research Program @pajiclab.bsky.social · 11/02/2025

Today on International Day of Women and Girls in Science, we celebrate the women in our lab driving discoveries to improve #PancreaticCancer patient outcomes. #IDWGS2025

011

Reposted by Dr Diana Schuhmacher

Pancreatic Cancer Therapeutics Research Program @pajiclab.bsky.social · 21/01/2025

We’re hiring! Do you want to join a passionate team working to improve outcomes of #PancreaticCancer patients? We’re looking for a senior research officer to join our team at the @garvaninstitute.bsky.social in Sydney, Australia. Apply here: garvan.wd3.myworkdayjobs.com/en-US/garvan... #AcademicSky

garvan.wd3.myworkdayjobs.com

Senior Research Officer

The Garvan Institute of Medical Research brings together world leading researchers and clinicians, collaborating locally and globally, to improve human health. Our mission is to harness all the inform...

011

Reposted by Dr Diana Schuhmacher

Pancreatic Cancer Therapeutics Research Program @pajiclab.bsky.social · 09/12/2024

Today we had a great team building day planning for a productive and science-filled 2025! Bring on the new year! 🧬🧫🧪🎉

032